Here are four things to know:
1. Lifeline Ventures and AO Invest, an investment fund backed by the AO Foundation, provided the funds.
2. Existing investors, such as HTGF, also participated in the funding round.
3. The Lifeline and AO investment brings the total equity invested into Synoste to $11.4 million.
4. Synoste is a Finland-based company that develops bone deformity solutions.
More articles on surface technology:
SpineEx receives FDA clearance for personalized lateral lumbar cage: 3 things to know
DePuy Synthes makes new partnership to promote knee spacer mold: 5 observations
CoreLink Surgical earns FDA clearance of 3D-printed interbody fusion device: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.